top of page
SEMAGLUTIDE
Overview
Semaglutide is a peptide that activates the glucagon-like peptide-1 (GLP-1) receptor. Clinical research has studied semaglutide extensively in relation to body weight, glucose regulation, appetite, and metabolic health.
Research has examined semaglutide in relation to body weight, waist circumference, glucose regulation, and other cardiometabolic measures. Research findings should be interpreted according to the population studied, study design, duration, dose, and specific endpoints being measured.
bottom of page